COLLABORATIVE RESEARCH ON PARASITIC DISEASES IN SUDAN

苏丹寄生虫病合作研究

基本信息

  • 批准号:
    3091503
  • 负责人:
  • 金额:
    $ 28.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1990
  • 资助国家:
    美国
  • 起止时间:
    1990-09-01 至 1994-08-31
  • 项目状态:
    已结题

项目摘要

The overall project objective is to carry forward a collaborative program of tropical parasitic disease research on several basic problems which underlie the major health priorities of the Republic of Sudan. The solutions we seek should permit inferences to be drawn which are of value to those involved in the characterization, prevention, treatment and control of parasitic diseases elsewhere in the tropics. Four widespread and important human parasitoses will be addressed: malaria, schistosomiasis, onchocerciasis and leishmaniasis. Malaria is by far the most important disease in Sudan; in the absence of chemotherapeutic or vector control interventions the outcome of infection is largely the result of host-immune response - parasite interactions. The nature of these, specifically with regard to T cell responsiveness to defined antigens and the pattern of cell-mediated effector mechanisms in well characterized subsets of endemic area populations form the focus for proposal #1. Contemporary approaches to schistosomiasis in the field depend on widespread use of anthelmintic drugs. The accurate assessment of their impact in terms of pathology and its resolution has only recently become possible using non-invasive ultrasound technology. In proposal #2 we extend our findings on cross-sectional analysis of Symmer;s fibrosis in affected communities to include biochemical and immunological correlates of the onset and disposition of pathologic changes in this most important component of schistosomal disease. The potential impact of ivermectin, a newly developed microfilaricidal agent, on onchocerciasis in Sudan is enormous. However, major questions remain about its pharmacology and mode of action and the role of host-immune responses in its efficacy in vivo and the adverse consequences of treatment. These will be explored in proposal #3 on onchocerciasis. Leishmaniasis, common in rural areas of eastern Sudan, involves immune mechanisms in its pathogenesis which are not well characterized. Longitudinal monitoring of cell-mediated and immunoglobulin types of responses in persons at different disease stages and during and after treatment will be used to establish mechanisms in its pathogenesis which are not well characterized. Longitudinal monitoring of cell-mediated and immunoglobulin types of responses in persons at different disease stages and during and after treatment will be used to establish mechanisms that operate in pathogenesis and after treatment will be used to establish mechanisms that operate in pathogenesis and in the onset of cure and perhaps protection (Project #4. Sustained involvement of Sudanese administrators, professionals, and technicians throughout this program will ensure enhancement of national research capacity for the future, and the research results should contribute to improvements in health care for the affected human populations throughout the country.
总体项目目标是进行协作计划 关于几个基本问​​题的热带寄生疾病研究 是苏丹共和国的主要健康重点。这 我们寻求的解决方案应允许提出有价值的推论 涉及参与特征,预防,治疗和 控制热带其他地方的寄生疾病。四个广泛 并将解决重要的人类寄生虫:疟疾, 血吸虫病,chocerceriasis和Leishmanisis。到目前为止,疟疾是 苏丹最重要的疾病;在没有化学治疗或 向量控制干预措施感染的结果在很大程度上是 宿主免疫反应的结果 - 寄生虫相互作用。的本质 这些,特别是关于T细胞对定义的响应的 抗原和细胞介导的效应器机制的模式 特有的特有地区人口的亚集构成了重点 提案#1。现代的血吸虫病方法 取决于广泛使用驱虫药。准确的评估 它们在病理学及其解决方面的影响只有 最近使用非侵入性超声技术成为可能。在 提案#2我们扩展了我们的发现 在受影响社区中的纤维化包括生化和 病理发作和处置的免疫学相关性 血吸虫病最重要组成部分的变化。这 伊维菌素的潜在影响,一种新开发的微丝剂, 在苏丹的尾尾cer虫上是巨大的。但是,仍然存在主要问题 关于它的药理学和作用方式以及宿主免疫的作用 其体内功效的反应和 治疗。这些将在OnChocerciasis提案3中进行探讨。 利什曼病在苏丹东部农村地区常见,涉及免疫 其发病机理中的机制未得到很好的特征。 细胞介导的和免疫球蛋白类型的纵向监测 在不同疾病阶段以及之后和之后的人反应 治疗将用于在其发病机理中建立机制 没有很好的特征。细胞介导的纵向监测和 在不同疾病阶段的人的免疫球蛋白类型的反应类型 在治疗期间和之后,将用于建立机制 在发病机理和治疗后将使用以建立 在发病机理和治愈发作中起作用的机制 也许保护(项目#4。苏丹人的持续参与 整个计划的管理人员,专业人士和技术人员 将确保增强未来国家研究能力,并 研究结果应有助于改善医疗保健 全国受影响的人口。

项目成果

期刊论文数量(100)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
African serum interference in the determination of chloroquine sensitivity in Plasmodium falciparum.
非洲血清干扰恶性疟原虫氯喹敏感性测定。
Chromosomes of Babesia bovis and Babesia bigemina.
牛巴贝虫和二联巴贝虫的染色体。
Prospects for prophylaxis of parasitism.
预防寄生的前景。
Plasma chloroquine measurement in the evaluation of Plasmodium falciparum sensitivity.
血浆氯喹测量评价恶性疟原虫敏感性。
Lack of cross-resistance to 4-aminoquinolines in chloroquine-resistant Plasmodium falciparum in vitro.
体外耐氯喹恶性疟原虫对 4-氨基喹啉缺乏交叉耐药性。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JEFFREY F WILLIAMS其他文献

JEFFREY F WILLIAMS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JEFFREY F WILLIAMS', 18)}}的其他基金

BIOCIDAL POLYMERS FOR DENTAL WATER CONTAMINATION CONTROL
用于控制牙科用水污染的杀菌聚合物
  • 批准号:
    2713304
  • 财政年份:
    1999
  • 资助金额:
    $ 28.62万
  • 项目类别:
ANTIMICROBIAL TEXTILES FOR HEALTHCARE WORKER PROTECTION
用于保护医护人员的抗菌纺织品
  • 批准号:
    2718040
  • 财政年份:
    1998
  • 资助金额:
    $ 28.62万
  • 项目类别:
BIOCIDAL POLYMERS FOR CONTROL OF DEVICE CONTAMINATION
用于控制设备污染的杀菌聚合物
  • 批准号:
    2715724
  • 财政年份:
    1998
  • 资助金额:
    $ 28.62万
  • 项目类别:
BIOCIDAL POLYMERS FOR VIRAL INACTIVATION IN PLASMA
用于灭活血浆病毒的杀菌聚合物
  • 批准号:
    2712400
  • 财政年份:
    1998
  • 资助金额:
    $ 28.62万
  • 项目类别:
PRODUCTION OF HUMAN ANTIMALARIAL CRISIS FORM FACTOR
人类抗疟危机因子的生产
  • 批准号:
    3488419
  • 财政年份:
    1986
  • 资助金额:
    $ 28.62万
  • 项目类别:
RECOMBINANT DNA GLYCOPROTEIN VACCINE
重组 DNA 糖蛋白疫苗
  • 批准号:
    3488341
  • 财政年份:
    1985
  • 资助金额:
    $ 28.62万
  • 项目类别:
COLLABORATIVE RESEARCH ON PARASITIC DISEASES IN SUDAN
苏丹寄生虫病合作研究
  • 批准号:
    3091495
  • 财政年份:
    1979
  • 资助金额:
    $ 28.62万
  • 项目类别:
COLLABORATIVE RESEARCH ON PARASITIC DISEASES IN SUDAN
苏丹寄生虫病合作研究
  • 批准号:
    3091498
  • 财政年份:
    1979
  • 资助金额:
    $ 28.62万
  • 项目类别:
EXPERIMENTAL PARASITOLOGY
实验寄生虫学
  • 批准号:
    3530966
  • 财政年份:
    1979
  • 资助金额:
    $ 28.62万
  • 项目类别:
EXPERIMENTAL PARASITOLOGY
实验寄生虫学
  • 批准号:
    3530965
  • 财政年份:
    1979
  • 资助金额:
    $ 28.62万
  • 项目类别:

相似海外基金

A functional characterization of Brugia malayi GABA-gated chloride channels: an unexplored target for antifilarial therapeutics
马来丝虫 GABA 门控氯离子通道的功能表征:抗丝虫治疗的未探索靶点
  • 批准号:
    10742453
  • 财政年份:
    2023
  • 资助金额:
    $ 28.62万
  • 项目类别:
Lead Optimization and Mechanisms of Action of Dual-Acting Antitrypanosomal Agents
双效抗锥虫药物的先导化合物优化及作用机制
  • 批准号:
    10172488
  • 财政年份:
    2021
  • 资助金额:
    $ 28.62万
  • 项目类别:
Target Validation for I-BET151-Induced Differentiation in the African Trypanosome
I-BET151 诱导非洲锥虫分化的目标验证
  • 批准号:
    10334561
  • 财政年份:
    2021
  • 资助金额:
    $ 28.62万
  • 项目类别:
Target Validation for I-BET151-Induced Differentiation in the African Trypanosome
I-BET151 诱导非洲锥虫分化的目标验证
  • 批准号:
    10218818
  • 财政年份:
    2021
  • 资助金额:
    $ 28.62万
  • 项目类别:
Lead Optimization and Mechanisms of Action of Dual-Acting Antitrypanosomal Agents
双效抗锥虫药物的先导化合物优化及作用机制
  • 批准号:
    10445231
  • 财政年份:
    2021
  • 资助金额:
    $ 28.62万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了